Subcutaneous omalizumab for people with asthma

Donovan, T. and Milan, S.J. and Adatia, A. and Solkar, Z. and Stovold, E. and Dwan, K. and Hinks, T.S.C. and Crossingham, I. (2021) Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews, 2021 (7). ISSN 1469-493X

[img]
Text (Donovan_et_al-2021-Cochrane_Database_of_Systematic_Reviews)
Donovan_et_al_2021_Cochrane_Database_of_Systematic_Reviews.pdf - Published Version
Restricted to Repository staff only until 22 July 2022.
Available under License Creative Commons Attribution-NonCommercial.

Download (150kB)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children.

Item Type:
Journal Article
Journal or Publication Title:
Cochrane Database of Systematic Reviews
Additional Information:
This is the version of record of the following protocol: Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K, Hinks TSC, Crossingham I. Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014975. DOI: 10.1002/14651858.CD014975. Accessed 19 August 2021 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014975/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700
Subjects:
ID Code:
158106
Deposited By:
Deposited On:
19 Aug 2021 15:25
Refereed?:
Yes
Published?:
Published
Last Modified:
20 Aug 2021 04:16